TREATMENT OF CANCERS USING ANTI-NKG2A AGENTS

• 收藏
• 分享

专利权人:

INNATE PHARMA

发明人:

ANDRE, PASCALE,BLERY, MATHIEU,SOULAS, CAROLINE,WAGTMANN, NICOLAÏ

申请号：

SG11201701388U

公开号：

SG11201701388UA

申请日:

2015.10.23

申请国别(地区):

SG

年份:

2017

代理人:

摘要：

The present disclosure relates to HLA-E as a tumor escape mechanism in head and neck cancer. The disclosure relates to methods for the treatment of head and neck cancer, notably HLA-E expressing head and neck squamous cell carcinoma, using antibodies that specifically bind and inhibit human NKG2A.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/